Akanda Corp. (AKAN) vs China SXT Pharmaceuticals, Inc. (SXTC)

Akanda Corp. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. is the larger, with a market value of $3.5M against $710.0K — 4.9× the size. Across the 5 metrics below, Akanda Corp. leads on 3 and China SXT Pharmaceuticals, Inc. on 2.

Valuation

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
P/E — n/m 19.25
P/S n/m n/m 2.11
P/B n/m n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 2.66 12.58
EV/Sales n/m (5.94) 2.73
Earnings yield — (159,014.29%) (4.38%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Gross margin — 36.69% 53.94%
Operating margin — 0.00% 0.00%
Net margin — (255.16%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.40%)
Return on assets 0.00% 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (53.98%) 10.01%
EPS growth (last fiscal year) (139.63%) 97.36% 49.06%
Revenue growth, 5-year CAGR 161.77% (24.94%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) 0.03 0.05
Current ratio 0.22 7.94 2.31
Net debt to EBITDA (2.75) 3.86 0.97

Dividend

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AKAN SXTC Drug Manufacturers Specialty & Generic median
Market cap 3.45m 710.00k 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack